SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

lululemon athletica, Inc. engages in the business of designing, distributing, and retailing technical athletic apparel, footwear, and accessories. It operates through the following segments: Company-Operated Stores, Direct to Consumer, and Other. The company was founded by Dennis James Wilson in 1998 and is headquartered in Vancouver, Canada.

Lululemon Athletica inc.

Lululemon Athletica Inc

Lululemon is trending due to a recently announced NFL apparel partnership with Fanatics, marking the brand's first foray into officially licensed NFL merchandise and expanding its reach into team sports apparel. The community is actively discussing the potential for Super Bowl ads and further collaborations, while some investors are speculating about a potential activist campaign led by founder Chip Wilson to shake up leadership. Despite positive news, concerns linger around tariffs and the company's growth strategy amid a broader market downturn.

Palantir Technologies, Inc. engages in the business of building and deploying software platforms that serve as the central operating systems for its customers. It operates through the Commercial and Government segments. The Commercial segment focuses on customers working in non-government industries. The Government segment is involved in providing services to customers that are the United States government and non-United States government agencies. Its platforms are widely used in areas such as defense, intelligence, healthcare, energy, and financial services, supporting data integration, large-scale analytics, and operational decision-making. The company was founded by Alexander Ceadmon Karp, Peter Andreas Thiel, Stephen Cohen, Joseph Lonsdale, and Nathan Dale Gettings in 2003 and is headquartered in Denver, CO.

Palantir Technologies Inc - Ordinary Shares - Class A

Palantir Technologies Inc

Palantir is trending as investors discuss its recent partnership with Lumen Technologies, a deal valued over $200 million, which is expected to boost enterprise AI adoption. The community is buzzing about the potential for Palantir to expand its reach within the AI infrastructure space. Technical analysis suggests a possible breakout to new all-time highs, with some focusing on earnings and revenue growth.

Richtech Robotics, Inc. engages in the development of robotic technologies. The firm designs, manufactures, and sells robots to restaurants, hotels, senior living centers, casinos, factories, and movie theaters. Its robots perform a variety of services including restaurant running and bussing, hotel room service delivery, floor scrubbing and vacuuming, and beverage and food preparation. The company was founded by Zhen Wu Huang and Zhen Qiang Huang on July 19, 2016 and is headquartered in Las Vegas, NV.

Richtech Robotics Inc. - Ordinary Shares - Class B

Richtech Robotics Inc.

Richtech Robotics is trending amid discussions about its partnership with the Vegas Golden Knights and anticipation for its humanoid robot reveal at the NVIDIA GTC conference. Community chatter revolves around potential breakthroughs in AI and robotics, as well as speculation about the company's long-term growth and partnerships. Some traders express concerns about short-term volatility and potential dilution, while others remain optimistic about Richtech's role in the future of service robotics.

United States Antimony Corp. engages in the extraction, processing and sale of antimony, zeolite, silver, and gold products. It operates through the following segments: United States Antimony Operations, Mexican Antimony Operations, Precious Metals Recovery, and United States Zeolite Operations. The company was founded by John C. Lawrence in June 1968 and is headquartered in Thompson Falls, MT.

United States Antimony Corp.

United States Antimony Corp

UAMY is trending amid discussions about a potential acquisition of Larvotto Resources and its significance for securing antimony supply, essential for defense and technology. Community members are weighing the implications of the deal, while some point to JP Morgan's investment in a competitor as a catalyst for sector-wide interest in antimony production. Despite recent price volatility and a rejected initial offer, the focus remains on UAMY's strategic position as a key domestic supplier.

Intellia Therapeutics, Inc. is a clinical stage genome editing company, which engages in the development of curative therapeutics using the CRISPR/Cas9 system. Its CRISPR/Cas9 system transforms medicine by both producing therapeutics that permanently edit and/or correct disease-associated genes in the human body with a single treatment course, and creates engineered cells that can treat oncological and immunological diseases. The company was founded by Andrew May, Luciano Marraffini, Rodolphe Barrangou, Nessan Bermingham, Rachel Haurwitz, Erik Sontheimer, Jennifer Doudna, and Derrick Rossi in May 2014 and is headquartered in Cambridge, MA.

Intellia Therapeutics Inc

Intellia Therapeutics is trending due to a temporary halt in Phase 3 trials for its gene therapy nex-z following a patient hospitalization with liver toxicity. The community is discussing whether this is a buying opportunity, comparing it to other biotech setbacks, and awaiting the company's conference call for further details. Broader context includes safety-related pauses being common in gene therapy trials, and the potential impact on the competitive landscape.

Click Holdings Ltd. operates as a holding company which provides temporary and permanent personnel solutions. Its services include professional solution services, nursing solution services, and logistics and other solution services. The company was founded by Chan Chun Sing on January 31, 2024 and is headquartered in Hong Kong.

Click Holdings Ltd. - Ordinary Shares - Class A

Click Holdings Limited

Click Holdings is experiencing heightened interest, spurred by a recent revenue growth update. The community is actively discussing the stock's volatility, low float, and potential for a significant price swing reminiscent of other low-float runners. Some are pointing to the company's expansion into senior care and potential commercial traction in Europe as drivers for future revenue.

GameStop Corp. engages in offering games and entertainment products through its ecommerce properties and stores. The firm’s stores and ecommerce sites operate primarily under the names GameStop, EB Games, and Micromania. It operates through the following geographical segments: United States, Canada, Australia, and Europe. The company was founded by Daniel A. DeMatteo in 1996 and is headquartered in Grapevine, TX.

Gamestop Corporation - Ordinary Shares - Class A

GameStop Corp

GameStop is trending as the White House reposted a meme from the company, sparking excitement among retail investors and talk of a potential short squeeze. The community is drawing comparisons to past meme stock rallies and analyzing the potential for significant price movement. Discussions also include speculation about the involvement of key figures and the overall market dynamics influencing the stock.

SoFi Technologies, Inc. is a financial service platform, which engages in the provision of student loan refinancing options to the private student loan market. It operates through the following segments: Lending, Technology Platform, and Financial Services. The Lending segment offers personal loans, student loans, home loan products, and related servicing activities. The Technology Platform segment focuses on technology products and solutions revenue. The Financial Services segment includes the SoFi Money product, SoFi Invest product, SoFi Credit Card product, SoFi Relay personal finance management product, and other financial services such as lead generation and content for other financial services institutions. The company was founded in 2011 and is headquartered in San Francisco, CA.

SoFi Technologies Inc

SoFi is trending as investors anticipate potential catalysts including strong earnings, a possible rate cut, and the addition of crypto trading to the platform. Community members are also speculating about potential S&P 500 inclusion in the near future. Some traders express concerns about short-term volatility and potential pullbacks, while long-term bulls remain confident in SoFi's growth prospects and innovative approach to digital banking.

Picard Medical, Inc. is a medical technology company, which manufactures and sells the only U.S. FDA, and Health Canada approved implantable SynCardia TAH. It develops the first fully implantable SynCardia TAH as an alternative to heart transplantation for patients with biventricular heart failure in the U.S. and around the world. The company is headquartered in Tucson, AZ.

Picard Medical Inc.

PMI is trending as the community discusses its recent price volatility and potential for a rebound, with some speculating about manipulation and others pointing to strong fundamentals. Bullish investors highlight the company's unique product and substantial revenue growth, while others express concern about potential dilutions and the stock's trading patterns. The company addressed the volatility with a statement noting no undisclosed material changes.

Avidity Biosciences, Inc. engages in the development of a new class of oligonucleotide-based therapies called Antibody Oligonucleotide Conjugates (AOC). It utilizes its AOC platform to design, engineer, and develop therapeutics that combine the tissue selectivity of monoclonal antibodies and the precision of oligonucleotide-based therapies in order to access previously undruggable tissue and cell types and more effectively target underlying genetic drivers of diseases. The company was founded by Troy E. Wilson, Kent Hawryluk, Mark E. Davis, and Francis Patrick McCormick on November 13, 2012 and is headquartered in San Diego, CA.

Avidity Biosciences Inc

Avidity Biosciences ($RNA) is trending amid speculation of a potential acquisition by Novartis (NVS) for $12B, which would grant Novartis access to Avidity's RNA therapeutics, particularly for neuromuscular diseases. Community discussions revolve around the potential deal's implications, with some traders expressing optimism for a continued squeeze, while analysts are quickly downgrading stock ratings. The broader context involves M&A activity in the biotech and banking sectors.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

CollPlant Expands its rhCollagen Distribution Capabilities in the United States and Canada

CollPlant Expands its rhCollagen Distribution Capabilities in the United States and Canada CollPlant Expands its rhCollagen Distribution Capabilities in the United States and Canada PR Newswire...

First-in-Kind Fully Humanized 3D Bioprinted Human Skin Model Developed by Mayo Clinic Researchers using CollPlant's rhCollagen-Based BioInk

First-in-Kind Fully Humanized 3D Bioprinted Human Skin Model Developed by Mayo Clinic Researchers using CollPlant's rhCollagen-Based BioInk First-in-Kind Fully Humanized 3D Bioprinted Human Skin...

CollPlant Expands Distribution for its VergenixSTR Product in Europe and Asia

CollPlant Expands Distribution for its VergenixSTR Product in Europe and Asia CollPlant Expands Distribution for its VergenixSTR Product in Europe and Asia PR Newswire REHOVOT, Israel, Feb. 24, 2025...

COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2024 THIRD QUARTER FINANCIAL RESULTS AND CONFERENCE CALL INFORMATION

COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2024 THIRD QUARTER FINANCIAL RESULTS AND CONFERENCE CALL INFORMATION COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2024 THIRD QUARTER FINANCIAL RESULTS AND...

CollPlant, Stratasys Initiate Study for Breast Implants

CollPlant Biotechnologies (NASDAQ: CLGN) and Stratasys Ltd.
read more...

Cracking The Code: Understanding Analyst Reviews For CollPlant Biotechnologies

Latest Ratings for CLGN
 DateFirmActionFromTo Feb 2021HC Wainwright & Co.MaintainsBuy May 2020HC Wainwright & Co.ReiteratesBuy Apr 2020HC Wainwright & Co.ReiteratesBuy
 View More Analyst Ratings...

CollPlant Announces Upcoming Shareholder Meeting

Collplant Holdings (CLGN) has released an update. CollPlant Biotechnologies Ltd. has announced its annual and extraordinary general meeting for sha...

CollPlant Pursues $3B Market with 3D-Printed Implants

Collplant Holdings (CLGN) has released an update. CollPlant Biotechnologies has initiated pre-clinical trials of 200cc regenerative breast implants...

COLLPLANT BIOTECHNOLOGIES REPORTS 2024 SECOND QUARTER FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE

COLLPLANT BIOTECHNOLOGIES REPORTS 2024 SECOND QUARTER FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE COLLPLANT BIOTECHNOLOGIES REPORTS 2024 SECOND QUARTER FINANCIAL RESULTS AND PROVIDES CORPORATE...

CollPlant and Stratasys Announce Pre-clinical Study for Regenerative Commercial-Sized Breast Implants

CollPlant and Stratasys Announce Pre-clinical Study for Regenerative Commercial-Sized Breast Implants CollPlant and Stratasys Announce Pre-clinical Study for Regenerative Commercial-Sized Breast...

CollPlant Biotechnologies Ltd. operates as a regenerative and aesthetic medicine company. It engages in the research, development, manufacture, and marketing of medical products for tissue repair such as bioprinting of tissues and organs, and medical aesthetics. Its products include VergenixSTR, VergenixFG, and Collink.3D. The company was founded by Oded Shoseyov in June 2004 and is headquartered in Rehovot, Israel.

CollPlant Biotechnologies Ltd - Ordinary Shares New

Cut 25 bps

Cut 50+ bps

No change

What will the Fed decide at its October meeting? Polymarket gives a 92% chance of a 25 bps cut. 
 
*Powered by Polymarket

Fiscal Period	Estimated	Reported	Surprise	Result
Q3 '25	$0.16	--	--	N/A
Q2 '25	-$0.10	-$0.28	-180.00%	MISSED
Q1 '25	-$0.04	$0.13	425.00%	BEAT
Q4 '24	-$0.13	-$0.33	-153.85%	MISSED
Q3 '24	-$0.28	-$0.38	-33.33%	MISSED

CLGN
CollPlant Biotechnologies Ltd - Ordinary Shares New

Feed

News

Sentiment

Earnings

Fundamentals

Info

Upcoming Earnings: Q3 '25

Historical Earnings

Latest CLGN News

CLGNCollPlant Biotechnologies Ltd - Ordinary Shares New